Jan 09, 2023 / 05:45PM GMT
Daniel G. Wolle - JPMorgan Chase & Co, Research Division - Analyst
Good morning, everyone. It's my pleasure to introduce -- my name is Daniel. I'm one of the analysts on this mid-cap biotech team. It's my pleasure to introduce Steve Hoerter from Deciphera. We don't have to go to a different room for the breakout session. So post the presentation, there will be mic runners if you want to ask questions or you can ask questions through the portal, and I'll be able to ask questions to that. Without further ado, Steve?
Steven L. Hoerter - Deciphera Pharmaceuticals, Inc. - President, CEO & Director
Great. Thanks, Daniel, very much for the kind introduction, and I'd like to thank the team at JPMorgan as well for the invitation to present at this year's conference. I'm excited to have the opportunity to share with you the outstanding progress we've made at Deciphera over the course of the past year and to share with you the 2023 milestones, which put us firmly on the path to being a company with multiple approved medicines around the world.
So as you
Deciphera Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript
Jan 09, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers